About 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide
2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide (PubChem CID 72874875) has the molecular formula C15H25N5O2
and a molecular weight of 307.40 g/mol. Its IUPAC name is 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide.
Analyze 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide?
The IUPAC name of 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide (CID 72874875) is 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide.
What is the SMILES notation for 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide?
The canonical SMILES for 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide is CC(C)NC(=O)CN1CCN(c2nnc(C3CCC3)o2)CC1.
What is the InChIKey of 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide?
The InChIKey is AWZHBONZDMEOCO-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H25N5O2/c1-11(2)16-13(21)10-19-6-8-20(9-7-19)15-18-17-14(22-15)12-4-3-5-12/h11-12H,3-10H2,1-2H3,(H,16,21).
What are the key properties of 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide?
2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide has a molecular weight of 307.40 g/mol, XLogP of 0.98, 5 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)piperazin-1-yl]-N-propan-2-ylacetamide is sourced from PubChem (CID 72874875), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).